LATEST
GTCR agreed to acquire CCC Intelligent SolutionsnewEQT agreed to acquire StockbridgenewMubadala Capital acquired Clear Channel OutdoorIthaca Holdings agreed to acquire BumblePenta Fine Ingredients acquired SynerzineHexagon agreed to acquire RocscienceSRS Acquiom / PantaraiSpaceX agreed to acquire nationwide 800 MHz spectrum portfolioAEA Investors acquired RensaWittington Investments agreed to acquire BootsEurazeo / MIYA Water: majority stakeMiddle River Power acquired Panoche Energy Center
Open App
Agreement signedPublished 24 Jul 2026

Scancell Holdings plc /
Neuphoria Therapeutics Inc.

Scancell Holdings plc and Neuphoria Therapeutics Inc. Merger Agreement

Buy side: Scancell Holdings plc
Buy sideScancell Holdings plc
Target: Neuphoria Therapeutics Inc.
TargetNeuphoria Therapeutics Inc.
Neuphoria Therapeutics Inc. · 24 Jul 2026Source
See the source
Follow Scancell Holdings plc Follow Neuphoria Therapeutics Inc.
Buy side: Scancell Holdings plc
Buy sideScancell Holdings plc
Target: Neuphoria Therapeutics Inc.
TargetNeuphoria Therapeutics Inc.
01 / BuyerScancell Holdings plc
02 / TargetNeuphoria Therapeutics Inc.
Source for the buyer and target: Neuphoria Therapeutics Inc.

For the buyer and target.

“On July 23, 2026, Neuphoria Therapeutics Inc., a Delaware corporation (the “ Company ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) with Scancell Holdings plc, a public limited company incorporated under the laws of England and Wales (“ Parent ”), and Scancell Merger Sub, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent (“ Merger Sub ”).”

Published 24 Jul 2026

Open the source
01

What happened

Neuphoria Therapeutics Inc. entered into a merger agreement with Scancell Holdings plc and Scancell Merger Sub, Inc. on July 23, 2026. The agreement provides for Scancell Merger Sub, Inc. to merge with and into Neuphoria Therapeutics Inc., which will survive as an indirect wholly owned subsidiary of Scancell Holdings plc. [01]

Under the agreement, eligible Neuphoria Therapeutics Inc. common stock will be exchanged for Scancell Holdings plc American Depositary Shares and one contingent value right. The exchange ratio will be calculated at the effective time. [01]

02

The source

Everything on this page comes from the source below, quoted word for word.

01
Source · Neuphoria Therapeutics Inc.

Scancell Holdings plc and Neuphoria Therapeutics Inc. Merger Agreement

This document is the source for the companies, stage and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Also stated

    “Scancell Holdings plc and Neuphoria Therapeutics Inc. Merger Agreement Neuphoria Therapeutics Inc. entered into a merger agreement with Scancell Holdings plc and Scancell Merger Sub, Inc. on July 23, 2026”

    Open the source

  2. Published by Neuphoria Therapeutics Inc.

    The source this page is built from.

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.

04

Deal Web

Every firm and person on this deal, and how they connect. Open any name to see their other deals.

Deal Web · 2 firms · 0 peopleHover a name to see how it connects
This dealScancell Holdings plc / Neuphoria Therapeutics Inc.Agreement signed · Published 24 Jul 2026
BuyerScancell Holdings plcTargetNeuphoria Therapeutics Inc.
This dealScancell Holdings plc / Neuphoria Therapeutics Inc.

Agreement signed · Scancell Holdings plc / Neuphoria Therapeutics Inc. deal (Agreement signed, published 24 Jul 2026).

Published 24 Jul 2026
Timeline
  1. Also stated
  2. Published by Neuphoria Therapeutics Inc.
Hover or tap a name to see how it connects, and when
Deal Web as a list